Myxoid liposarcomas (MLS) are rare, malignant, mesenchymal tumors characterized by specific translocations t(12;16) and t(12;22) with limited additional driver mutations, most notably in PIK3CA and the TERT promoter. This evidence concerns the gene PIK3CA and myxoid liposarcoma.